File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.3389/fimmu.2021.691559
- Scopus: eid_2-s2.0-85111022963
- PMID: 34122457
- WOS: WOS:000660087200001
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Roles of IL-25 in Type 2 Inflammation and Autoimmune Pathogenesis
Title | Roles of IL-25 in Type 2 Inflammation and Autoimmune Pathogenesis |
---|---|
Authors | |
Keywords | IL-25 IL-25 signal transduction type 2 inflammation systemic erythematosus lupus rheumatoid arthritis |
Issue Date | 2021 |
Publisher | Frontiers Research Foundation. The Journal's web site is located at http://www.frontiersin.org/immunology |
Citation | Frontiers in Immunology, 2021, v. 12, p. article no. 691559 How to Cite? |
Abstract | Interleukin-17E (IL-25) is a member of the IL-17 cytokine family that includes IL-17A to IL-17F. IL-17 family cytokines play a key role in host defense responses and inflammatory diseases. Compared with other IL-17 cytokine family members, IL-25 has relatively low sequence similarity to IL-17A and exhibits a distinct function from other IL-17 cytokines. IL-25 binds to its receptor composed of IL-17 receptor A (IL-17RA) and IL-17 receptor B (IL-17RB) for signal transduction. IL-25 has been implicated as a type 2 cytokine and can induce the production of IL-4, IL-5 and IL-13, which in turn inhibits the differentiation of T helper (Th) 17. In addition to its anti-inflammatory properties, IL-25 also exhibits a pro-inflammatory effect in the pathogenesis of Th17-dominated diseases. Here, we review recent advances in the roles of IL-25 in the pathogenesis of inflammation and autoimmune diseases. |
Persistent Identifier | http://hdl.handle.net/10722/305083 |
ISSN | 2023 Impact Factor: 5.7 2023 SCImago Journal Rankings: 1.868 |
PubMed Central ID | |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Deng, C | - |
dc.contributor.author | Peng, N | - |
dc.contributor.author | TANG, Y | - |
dc.contributor.author | Yu, N | - |
dc.contributor.author | Wang, C | - |
dc.contributor.author | Cai, X | - |
dc.contributor.author | Zhang, L | - |
dc.contributor.author | Hu, D | - |
dc.contributor.author | Ciccia, F | - |
dc.contributor.author | Lu, L | - |
dc.date.accessioned | 2021-10-05T02:39:29Z | - |
dc.date.available | 2021-10-05T02:39:29Z | - |
dc.date.issued | 2021 | - |
dc.identifier.citation | Frontiers in Immunology, 2021, v. 12, p. article no. 691559 | - |
dc.identifier.issn | 1664-3224 | - |
dc.identifier.uri | http://hdl.handle.net/10722/305083 | - |
dc.description.abstract | Interleukin-17E (IL-25) is a member of the IL-17 cytokine family that includes IL-17A to IL-17F. IL-17 family cytokines play a key role in host defense responses and inflammatory diseases. Compared with other IL-17 cytokine family members, IL-25 has relatively low sequence similarity to IL-17A and exhibits a distinct function from other IL-17 cytokines. IL-25 binds to its receptor composed of IL-17 receptor A (IL-17RA) and IL-17 receptor B (IL-17RB) for signal transduction. IL-25 has been implicated as a type 2 cytokine and can induce the production of IL-4, IL-5 and IL-13, which in turn inhibits the differentiation of T helper (Th) 17. In addition to its anti-inflammatory properties, IL-25 also exhibits a pro-inflammatory effect in the pathogenesis of Th17-dominated diseases. Here, we review recent advances in the roles of IL-25 in the pathogenesis of inflammation and autoimmune diseases. | - |
dc.language | eng | - |
dc.publisher | Frontiers Research Foundation. The Journal's web site is located at http://www.frontiersin.org/immunology | - |
dc.relation.ispartof | Frontiers in Immunology | - |
dc.rights | This Document is Protected by copyright and was first published by Frontiers. All rights reserved. It is reproduced with permission. | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | IL-25 | - |
dc.subject | IL-25 signal transduction | - |
dc.subject | type 2 inflammation | - |
dc.subject | systemic erythematosus lupus | - |
dc.subject | rheumatoid arthritis | - |
dc.title | Roles of IL-25 in Type 2 Inflammation and Autoimmune Pathogenesis | - |
dc.type | Article | - |
dc.identifier.email | Deng, C: dchong12@connect.hku.hk | - |
dc.identifier.email | Lu, L: liweilu@hku.hk | - |
dc.identifier.authority | Lu, L=rp00477 | - |
dc.description.nature | published_or_final_version | - |
dc.identifier.doi | 10.3389/fimmu.2021.691559 | - |
dc.identifier.pmid | 34122457 | - |
dc.identifier.pmcid | PMC8194343 | - |
dc.identifier.scopus | eid_2-s2.0-85111022963 | - |
dc.identifier.hkuros | 326249 | - |
dc.identifier.volume | 12 | - |
dc.identifier.spage | article no. 691559 | - |
dc.identifier.epage | article no. 691559 | - |
dc.identifier.isi | WOS:000660087200001 | - |
dc.publisher.place | Switzerland | - |